Physician profile
Bryan Davis
NPI 1205361276
$3,654.03
in general payments reported to CMS, 2019-2025
8 companies · $214 in 2025
The $214 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $956 · 2023: $1,098 · 2024: $1,386 · 2025: $214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,687 · Food and Beverage: $1,011.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,687.18 |
| Food and Beverage | $1,011.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,340.87 | 2022-2025 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim, Synchromedii |
| Boston Scientific Corporation | $1,126.13 | 2022-2025 | Infinion 16, Wavewriter Alpha Prime 16 |
| Abbvie INC. | $44.29 | 2024 | |
| Saluda Medical Americas, INC. | $39.28 | 2025 | Evoke |
| Globus Medical, INC. | $33.82 | 2025 | Senza |
| Avanos Medical | $31.21 | 2025 | Coolief Cooled Radiofrequency, Generator |
| Abbott Laboratories | $29.45 | 2025 | Eterna |
| Grt US Holding, INC. | $8.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.